Related Experiment Video
Updated: May 1, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Skull base osteomyelitis: incidence of resistance, morbidity, and treatment strategy
Nicolas Le Clerc1, Benjamin Verillaud, Michele Duet
1Department of Otorhinolaryngology, Lariboisière Hospital, Paris, France.
Objectives/Hypothesis:
The pathogeny of osteomyelitis of the skull base has evolved over time with the emergence of ciprofloxacin-resistant Pseudomonas strains and significant fungal infections, both of which seem to bring a higher morbidity. The aims of this study were 1) to document the incidence of ciprofloxacin-resistant Pseudomonas aeruginosa over the past 7 years; 2) to assess morbidity by a radiologic score, the occurrence of cranial nerve palsies, and the duration of the hospital stay, according to the pathogenesis; and 3) to propose a treatment strategy.
Study Design:
Retrospective chart review of necrotizing external otitis cases from 2004 to 2011. The setting was the Department of ENT Surgery, Lariboisière Hospital, Paris.
Methods:
Thirty-one patients were included. Radiological scores were assessed based on the initial computed tomography scans or magnetic resonance imaging, which specified the anatomical territory involved. Nerve palsies, the duration of hospitalization, and the radiological scores were analyzed with regard to the pathogen.
Results:
Twenty-eight patients had a bacterial disease. Of the 20 strains of P. aeruginosa identified, five (25%) were ciprofloxacin-resistant P. aeruginosa. Three patients (10%) had a fungal infection due to Aspergillus flavus. Nerve palsies, radiological scores, and hospitalization durations were significantly higher for patients with resistant strains and A. flavus.
Conclusions:
In our series, the prevalence of ciprofloxacin-resistant Pseudomonas strains increased over time. Along with fungal infections, they formed a group with a higher morbidity than that of ciprofloxacin-sensitive Pseudomonas infections that furthermore did not respond to oral outpatient treatment. This is why pathogen identification using biopsies is sometimes required to start a prolonged treatment.
Insights
The incidence of ciprofloxacin-resistant Pseudomonas strains and fungal infections in skull base osteomyelitis has increased, leading to higher morbidity. Prompt pathogen identification is crucial for effective, prolonged treatment strategies.
Area of Science:
- Infectious Diseases
- Otolaryngology
- Radiology
Background:
- Skull base osteomyelitis pathogeny is evolving with emerging resistant bacterial strains and fungal infections.
- These evolving pathogens are associated with increased patient morbidity.
Purpose of the Study:
- To document the incidence of ciprofloxacin-resistant Pseudomonas aeruginosa over seven years.
- To assess morbidity (radiologic score, cranial nerve palsies, hospital stay) based on pathogen type.
- To propose an optimized treatment strategy for skull base osteomyelitis.
Main Methods:
- Retrospective chart review of necrotizing external otitis cases (2004-2011).
- Inclusion of 31 patients.
- Assessment of radiologic scores, cranial nerve palsies, and hospitalization duration based on identified pathogens.
Main Results:
- 25% of Pseudomonas aeruginosa strains (5/20) were ciprofloxacin-resistant.
- 10% of patients (3/31) had fungal infections (Aspergillus flavus).
- Higher morbidity (nerve palsies, radiologic scores, hospitalization) observed in patients with resistant strains and fungal infections.
Conclusions:
- Prevalence of ciprofloxacin-resistant Pseudomonas strains and fungal infections in skull base osteomyelitis has increased.
- These infections present higher morbidity compared to sensitive Pseudomonas infections.
- Pathogen identification via biopsy is essential for initiating prolonged, effective treatment.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Brain Abscess l: Introduction
Endocarditis III: Medical Management
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
